The authors declare that they have no competing interests.
YPZ and DB performed the systematic review and meta-analysis. HLZ, GHS, and DWY identified the studies and participated in critical evaluation and discussion. All authors read and approved the final manuscript.
The ability of 5α-reductase inhibitors (5ARIs) to decrease blood loss during transurethral resection of the prostate (TURP) for benign prostatic hyperplasia (BPH) remains controversial. We aimed to conduct a meta-analysis of all randomized controlled trials (RCTs) to establish the role of 5ARI use prior to TURP.
We searched studies from the electronic databases PubMed, Embase, Scopus, and Cochrane Library from inception to March 25, 2014. Meta-analysis was performed using the statistical software Review Manager version 5.1.
Seventeen RCTs including 1489 patients were examined. We observed that preoperative treatment with finasteride can decrease total blood loss, blood loss per gram of resected prostate tissue, hemoglobin level alteration, microvessel density (MVD), and vascular endothelial growth factor level. Neither finasteride nor dutasteride reduced operative time, prostate volume, or the weight of gland resected. In contrast, pretreatment with dutasteride before TURP did not decrease the total blood loss or MVD.
Pretreatment with finasteride does seem to reduce perioperative blood loss related to TURP for BPH patients. However, the effect of preoperative dutasteride was inconclusive. Further studies are required to strengthen future recommendations regarding the use of 5ARI as a standard pre-TURP treatment and its optimal regimen.
Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC. Transurethral prostatectomy: immediate and postoperative complications. Cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol. 1989;141:243–7. PubMed
Liu XD, Yang YR, Lu YP, Zhang XH, Li FY, Wei Q, et al. Preoperative finasteride on decreasing operative bleeding during transurethral resection of prostate. Chin J Urol. 2003;24:694–6.
Li GH, He ZF, Yu DM, Li XD, Chen ZD. Effect of finasteride on intraoperative bleeding and irrigating fluid absorption during transurethral resection of prostate: a quantitative study. J Zhejiang Univ (Med Sci). 2004;33:258–60.
Berardinis ED, Antonini G, Busetto GM, Gentile V, Silverio FD, Rossi A. Reduced intraoperative bleeding during transurethral resection of the prostate: evaluation of finasteride, vascular endothelial growth factor, and CD34. Curr Prostate Rep. 2008;6:123–7. CrossRef
Liu Y, Hou TH, Jiang HM, Feng YH, Zhang L. Clinical research on preoperative application of finasteride in reducing transurethral resection syndrome. Shan Dong Med drugs. 2013;26:22–4.
He EB, Li JF. Effect of different doses of preoperative finasteride on the bleeding during transurethral resection of prostate. J Mod Urol. 2012;17:287–9.
Boccon-Gibod L, Valton M, Ibrahim H, Comenducci A. Effect of dutasteride on reduction of intraoperative bleeding related to transurethral resection of the prostate. Prog Urol. 2005;15:1085–9. PubMed
Arena F. Role of short term treatment with dutasteride in transurethral prostate resection. Trends in Med. 2008;8:103–6.
Yu XX, Zhou DQ, Mo ZN, Li WG, Wang J, Liu SW, et al. The clinical application of finasteride in peri-operation of transurethral plasmakinetic enucleation of prostate. Chin J Geriatr. 2011;30:930–3.
- Impact of preoperative 5α-reductase inhibitors on perioperative blood loss in patients with benign prostatic hyperplasia: a meta-analysis of randomized controlled trials
- BioMed Central
Neu im Fachgebiet Urologie
Meistgelesene Bücher in der Urologie
Mail Icon II